Advanced her2-positive breast cancer Clinical Trials
Conditions / Advanced her2-positive breast cancer
Delta Trials indexes 2 clinical trials for Advanced her2-positive breast cancer in its publicly accessible dataset. Of these, 0 enrolling participants at this time and 2 trials have reached completion. This research takes place spanning 17 research sites around the world. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
2
Total Trials
0
Recruiting
2
Completed
0
Other Active
0
Terminated since 2020
17
Study Locations
Browse by location (17 total)
- Fayetteville, United States 1 trialAll trials in Fayetteville, United States
- Leicester, United Kingdom 1 trialAll trials in Leicester, United Kingdom
- Saint-herblain Cédex, France 1 trialAll trials in Saint-herblain Cédex, France
- Oxford, United Kingdom 1 trialAll trials in Oxford, United Kingdom
- Manchester, United Kingdom 1 trialAll trials in Manchester, United Kingdom
- Santiago de Compostela, Spain 1 trialAll trials in Santiago de Compostela, Spain
- Essen, Germany 1 trialAll trials in Essen, Germany
- Candiolo, Italy 1 trialAll trials in Candiolo, Italy
- Birmingham, United Kingdom 1 trialAll trials in Birmingham, United Kingdom
- Málaga, Spain 1 trialAll trials in Málaga, Spain
- Málaga, Spain 1 trialAll trials in Málaga, Spain
- Tübingen, Germany 1 trialAll trials in Tübingen, Germany
- Tȕbingen, Germany 1 trialAll trials in Tȕbingen, Germany
- Stockholm, Sweden 1 trialAll trials in Stockholm, Sweden
- Boston, United States 1 trialAll trials in Boston, United States
- Dijon, France 1 trialAll trials in Dijon, France
- Singapore, Singapore 1 trialAll trials in Singapore, Singapore
- Prato, Italy 1 trialAll trials in Prato, Italy
- Madrid, Spain 1 trialAll trials in Madrid, Spain